Ginsenoside Rh2-B1 Stimulates Cell Proliferation and IFN-γ Production by Activating the P38 MAPK and ERK-dependent Signaling Pathways in CTLL-2 Cells.
Shuang Lv,Peng-Fei Yi,Hai-Qing Shen,Li-Yan Zhang,Hai-Bing Dong,Shuai-Cheng Wu,Fang Xia,Xun Guo,Xu-Bin Wei,Ben-Dong Fu
DOI: https://doi.org/10.3109/08923973.2013.864669
IF: 3.712
2013-01-01
Immunopharmacology and Immunotoxicology
Abstract:Context: Ginsenoside Rh2, an active component of ginseng, exhibits immunoregulatory and anti-inflammatory properties. Rh2-B1, a sulfated derivative, was prepared to enhance its water solubility. We studied the effect of Rh2-B1 on CTLL-2, a CD8(+) cytotoxic T cell line that was known for protecting against viral infection.Objective: We aimed to investigate the effect of Rh2-B1 on interferon (IFN)-gamma production and cell proliferation and its possible mechanism. Materials andmethods: Enzyme-linked immunosorbent assay ( ELISA) was employed to analyze the IFN-gamma concentration of the whole blood and the supernatant of CTLL-2 cell culture. Cell proliferation assay was conducted using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Western blots were used to evaluate changes in signal transduction pathways in CTLL-2 cells.Results: Rh2-B1 was able to enhance IFN-gamma production from whole blood culture of Balb/c mice. We then evaluated the effect of Rh2-B1 on a cytotoxic T cell line, CTLL-2 for cell proliferation, IFN-gamma production and its molecular mechanism. Rh2-B1 promoted cell proliferation and IFN-g production of CTLL-2 cells. It also induced activation of p38 mitogen-activated protein kinase ( MAPK) and extracellular-signal-regulated kinases (ERK), but inhibited p56 Lck and transducer and activator of transcription 5 (STAT5) expression. The effect was blocked by the specific p38 MAPK inhibitor SB203580 and ERK inhibitor U0126.Conclusion: Rh2-B1 could stimulate cell proliferation and IFN-g production by activating the p38 MAPK- and ERK-dependent signaling pathways in cytotoxic T cells. This may be a novel medicine for treatment of viral infections.
What problem does this paper attempt to address?